Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirill A Afonin

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Nanomaterials (Basel, Switzerland)|April 25, 2019
Smart-Responsive Nucleic Acid Nanoparticles (NANPs) with the Potential to Modulate Immune BehaviorMorgan Chandler, Kirill A Afonin
Methods in Molecular Biology (Clifton, N.J.)|August 12, 2023
Structural Characterization of DNA-Templated Silver Nanoclusters by Energy Dispersive SpectroscopyDamian Beasock, Kirill A Afonin
Advanced Drug Delivery Reviews|June 18, 2021
Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs)Weina Ke, Kirill A Afonin
Journal of the American Chemical Society|December 15, 2006
Generating new specific RNA interaction interfaces using C-loopsKirill A Afonin, Neocles B Leontis
Nature Protocols|October 24, 2020
Use of human peripheral blood mononuclear cells to define immunological properties of nucleic acid nanoparticlesMarina A Dobrovolskaia, Kirill A Afonin
Advanced Drug Delivery Reviews|December 18, 2022
Editorial to "Molecular engineering of biomaterials programmed to operate in living systems"Kirill A Afonin, Nikolay V Dokholyan
Nanomaterials (Basel, Switzerland)|July 3, 2019
Editorial for the Special Issue on "Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials"Justin R Halman, Kirill A Afonin
Molecules (Basel, Switzerland)|June 28, 2023
Special Issue "Nanotechnology to Overcome the World's Most Critical Health Issues: Liposomes and Beyond-A Themed Issue Dedicated to Professor Yechezkel Barenholz"Marina A Dobrovolskaia, Kirill A Afonin
Molecular Therapy. Nucleic Acids|September 8, 2023
RNA nanoparticles for targeted therapies of triple-negative breast cancersLeyla Danai, Eva Ge, Kirill A Afonin
Frontiers in Immunology|August 24, 2023
Editorial: Delivering nucleic acids to immune and non-immune cellsKirill A Afonin, Francesca Re, Diana Boraschi
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Nanomaterials (Basel, Switzerland)|April 25, 2019
Smart-Responsive Nucleic Acid Nanoparticles (NANPs) with the Potential to Modulate Immune BehaviorMorgan Chandler, Kirill A Afonin
Methods in Molecular Biology (Clifton, N.J.)|August 12, 2023
Structural Characterization of DNA-Templated Silver Nanoclusters by Energy Dispersive SpectroscopyDamian Beasock, Kirill A Afonin
Advanced Drug Delivery Reviews|June 18, 2021
Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs)Weina Ke, Kirill A Afonin
Journal of the American Chemical Society|December 15, 2006
Generating new specific RNA interaction interfaces using C-loopsKirill A Afonin, Neocles B Leontis
Nature Protocols|October 24, 2020
Use of human peripheral blood mononuclear cells to define immunological properties of nucleic acid nanoparticlesMarina A Dobrovolskaia, Kirill A Afonin
Advanced Drug Delivery Reviews|December 18, 2022
Editorial to "Molecular engineering of biomaterials programmed to operate in living systems"Kirill A Afonin, Nikolay V Dokholyan
Nanomaterials (Basel, Switzerland)|July 3, 2019
Editorial for the Special Issue on "Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials"Justin R Halman, Kirill A Afonin
Molecules (Basel, Switzerland)|June 28, 2023
Special Issue "Nanotechnology to Overcome the World's Most Critical Health Issues: Liposomes and Beyond-A Themed Issue Dedicated to Professor Yechezkel Barenholz"Marina A Dobrovolskaia, Kirill A Afonin
Molecular Therapy. Nucleic Acids|September 8, 2023
RNA nanoparticles for targeted therapies of triple-negative breast cancersLeyla Danai, Eva Ge, Kirill A Afonin
Frontiers in Immunology|August 24, 2023
Editorial: Delivering nucleic acids to immune and non-immune cellsKirill A Afonin, Francesca Re, Diana Boraschi
Pageof 14